Back to Search
Start Over
Determinants of p16/Ki-67 adequacy and positivity in HPV-positive women from a screening population
- Publication Year :
- 2021
-
Abstract
- BACKGROUND The objective of this study was to describe the determinants of adequacy and positivity of the p16/Ki-67 assay in a human papillomavirus (HPV)-positive screening population enrolled within the New Technologies for Cervical Cancer 2 (NTCC2) study. METHODS ThinPrep slides were immunostained for p16/Ki-67; each slide had 3 reports from different laboratories. The authors included population-related, sampling-related/staining-related, and interpretation-related variables in the analyses. Adequacy and positivity proportions were stratified by variables of interest. Univariate and multivariate logistic models were used to identify determinants of adequacy and positivity. RESULTS In total, 3100 consecutive HPV-positive cases were analyzed. Because every slide was interpreted by 3 centers, 9300 reports were obtained, including 905 (9.7%) that were inadequate and 2632 (28.3%) that were positive. The percentage of cases in which all 3 reports were inadequate increased with increasing age of the women and with inadequate cytology. The highest percentage of adequacy in all 3 reports and of cases with all 3 reports positive was observed in specimens from women who had grade ≥2 cervical intraepithelial neoplasia (CIN2+), atypical squamous cells of undetermined significance or more severe (ASC-US+) cytology, or mRNA positivity. The number of inadequate reports was significantly associated with increasing age, inadequate cytology, mRNA negativity, and scant cellularity. A positive p16/Ki-67 report was associated with an ASC-US+ result and with a positive mRNA result in cases both with and without CIN2+ but was associated with an HPV type 16 and/or 18 infection only in CIN2+ cases. The presence of CIN2+ was strongly associated with dual staining positivity. CONCLUSIONS The interpretation of p16/Ki-67 results may be influenced by several different variables, all of which are part of the steps in the procedure, and by the characteristics of the screened population.
- Subjects :
- Adult
Cancer Research
medicine.medical_specialty
Cytodiagnosis
Population
cervical cancer screening
Uterine Cervical Neoplasms
030209 endocrinology & metabolism
p16
Atypical Squamous Cells
dual immunostaining
Cervical intraepithelial neoplasia
03 medical and health sciences
0302 clinical medicine
immunocytochemistry
Cytology
medicine
Atypical Squamous Cells of the Cervix
Biomarkers, Tumor
Humans
Mass Screening
Human papillomavirus
education
human papillomavirus
Papillomaviridae
INK4a
Cyclin-Dependent Kinase Inhibitor p16
Cervical cancer
Vaginal Smears
education.field_of_study
biology
business.industry
Obstetrics
HPV Positive
Papillomavirus Infections
Middle Aged
medicine.disease
Uterine Cervical Dysplasia
Ki-67 Antigen
Oncology
Italy
030220 oncology & carcinogenesis
Ki-67
biology.protein
Female
business
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....2112e25abbfb2704f7e2dfdb18eb7f41